Analysed GENMAB A/S (GNMSF:OTCMKTS) News Sources
GMAB Stock Hits All-Time High After Genmab’s Cancer Drug Trial Meets Primary Goals — Here’s What Investors Need To Know
28-10-2026
stocktwits.com
Genmab’s Three Positive Phase III Readouts Set Stage for Potential 2027 Cancer Launches
28-10-2026
marketbeat.com
What is the current price of GENMAB A/S (GNMSF:OTCMKTS)?
The current price of GENMAB A/S (GNMSF:OTCMKTS) is $563.82.
GENMAB A/S (GNMSF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GENMAB A/S (GNMSF:OTCMKTS) since the previous trading day is $8.5201.
GENMAB A/S (GNMSF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GENMAB A/S (GNMSF:OTCMKTS) since the previous trading day is 1.5343%.
What is the most recent average sentiment score for GENMAB A/S (GNMSF:OTCMKTS)?
The most recent average sentiment score for GENMAB A/S (GNMSF:OTCMKTS) is 73 out of 100.
What is the most recent average sentiment for GENMAB A/S (GNMSF:OTCMKTS)?
The most recent sentiment for GENMAB A/S (GNMSF:OTCMKTS) is .
SEC-8K** Filing Available For GENMAB A/S (GNMSF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.